Asia Fresh News

Asia Fresh Stories

Archive for January 17th, 2013

Dates for FMC China 2013 Furniture Manufacturing & Supply China Announced

leave a comment »

Running Concurrently with FMC Premium 2013 and Furniture China 2013 from 11-14 September 2013, Shanghai World Expo Exhibition & Convention Center

Woodworking Machinery, Furniture Raw Materials

850 Exhibitors, 71,000 Sqm, 35,000 Trade Buyers

Focus on Furthering Upstream and Downstream Industry Chains

The FMC China Exhibition provides the best woodworking machinery and furniture raw materials for the world’s furniture industry.

SHANGHAI, Jan. 15, 2013 /PRNewswire/ — Furniture Manufacturing & Supply China 2013 (FMC China 2013) will be staged at the Shanghai World Expo Exhibition & Convention Center (SWEECC) from 11-14 September, 2013. The show will comprise four indoor halls, H1, H2, H3, and H4. The total surface area will be 71,000 sqm and it is expected to attract 850 exhibitors.
FMC China 2012 Onsite Photo
FMC China 2012 Onsite Photo

FMC Premium 2012 Onsite Photo
FMC Premium 2012 Onsite Photo

FMC China 2013 will be held concurrently with Furniture China 2013, one of the biggest furniture shows in the world. The visitor’s badge is valid for both shows and a shuttle bus will be specially arranged for visitors’ convenience.

FMC has been successfully held for 18 years. FMC China 2012 attracted 761 exhibitors and 30,759 trade buyers from 111 countries and regions. The Taiwan Pavilion, the States of North Carolina and Pennsylvania hardwood Pavilions, as well as associations and groups from Malaysia, Mexico, India and Vietnam all participated.

The exhibits included Woodworking Machinery & Tools, Furniture Coating & Chemicals, Furniture Hardware & Fittings, Furniture Inspection, Design & Services, Furniture Panels & Surface Decor, Cabinet & Wardrobe Fittings/Furniture Lightings, Furniture Fabric & Leather, Upholstery Furniture Components & Supplies, and Office Furniture Supplies & Gas Springs. Semi-finished Furniture will be launched in 2013.

The organiser has expanded the exhibition area for woodworking and machinery so that visitors will gain a more comprehensive onsite experience.

Hall 1 – First Floor

o Woodworking Machinery & Tools

Hall 2 – First Floor

o FMC Premium 2013

o Upholstery Machinery

o Coating Equipment

o CNC Machinery

Hall 3 – Second Floor
Furniture Raw Materials & Components Area with Seven Themed Sections

o Furniture Hardware & Fittings

o Furniture Inspection, Design & Services

o Cabinet/Wardrobe Fittings & Furniture Lighting Accessories

o Furniture Panels & Surface Decor

o Furniture Fabric & Leather

o Upholstery Furniture Components & Supplies

o Semi-finished Furniture

Hall 4 – Underground Floor
o Office Furniture Supplies & Gas Springs
o Furniture Coatings, Adhesives & Chemicals Products

Running Concurrently with Furniture China 2013, Furthering the Upstream and Downstream Industry Chains

FMC China 2013 will emphasize the development of the whole industry in the Chinese furniture market and enhance industry chain linkage, providing sound foundations for furniture and equipment manufacturing components, thereby enabling China to become the foremost furniture manufacturing nation.

The New Products, New Technologies and New Materials Collection areas will be arranged both in SNIEC and SWEECC. These professional showcases will build a bridge for exhibitors and trade buyers, benefiting both sides by generating direct communication between the upstream and downstream industry enterprises.

For further enquiries, please contact:

Shanghai UBM Sinoexpo International Exhibition Co. Ltd.
Tel: 86-21-64371178
Fax: 86-21-61154988
Email: fmc@ubmsinoexpo.com
Website: http://www.fmcchina.com.cn

Written by asiafreshnews

January 17, 2013 at 3:44 pm

Posted in Uncategorized

Economist Intelligence Unit Report Calls for Global Policy Innovation to Tackle the ‘Silent Pandemic’ That is Hepatitis C

leave a comment »

– Experts recommend comprehensive approach to combat global health issue –
LONDON/PRNewswire/ —
A new Economist Intelligence Unit (EIU) report titled The Silent Pandemic: Tackling Hepatitis C with Policy Innovation, made possible as a result of an educational grant from Janssen Pharmaceutica NV and published today, highlights the urgent need for countries around the world to develop strategies to tackle head-on the growing social and economic issues associated with Hepatitis C (HCV).(1)
To view the Multimedia News Release, please click: http://www.multivu.com/mnr/58671-janssen-silent-pandemic-hepatitis-c
While the total number of infected individuals is unknown due to a lack of available data, the World Health Organization (WHO) estimates that approximately 150 million people globally are currently living with the blood-borne infectious disease, HCV.(2) Of these, up to two thirds will develop chronic liver disease and one in five will develop cirrhosis.(2) HCV is also the leading cause of liver transplantation worldwide[1] and in the US the disease now accounts for more deaths than HIV.(1)
“The report highlights that worldwide, despite the significant burden of HCV, governments have failed to get a grip on the scale and impact of the disease,” said Charles Gore, President of The World Hepatitis Alliance. “In both developed and developing countries, the true human and economic cost of HCV will continue to rise unless policy makers confront this urgent public health issue now.”
Despite the devastating effects of HCV, the report states that it is now considered preventable and with modern treatments, the majority of suffers can become clear of the virus.(1) The report notes, however, that as few as 10% of patients are currently receiving treatments and there is a large disparity in care across countries.(1) As a result, the report calls for countries to take a “comprehensive approach,” which takes into account local needs and resources available. This includes the following:(1)
Effective disease surveillance to create an accurate picture of the problem and ensure effective policies can be developed. The report claims that too few countries – developed or developing – have recently conducted the epidemiological studies necessary for good policy-making at a national, let alone a local, level. According to the EIU, 16 countries in the EU alone have epidemiological data that is either poor or non-existent.(1)
Better public awareness is needed to help remove the stigma associated with the disease and create better understanding of HCV.(1) A survey by the European Liver Patients Association found that only 20% of those diagnosed had heard of hepatitis B or C before being told they had it(1) (full survey results are available at: http://www.hepbcppa.org/wp-content/uploads/2011/11/Report-on-Patient-Self-Help.pdf).
Prevention measures to reduce high-risk behaviour and improve education on healthy lifestyle choices for those already infected. The report also calls for measures to prevent transmission via healthcare systems, which is the major route of transmission of HCV in developing countries.(1)
Innovative ways to reach out to patients to ensure those who need treatment receive it before irreversible conditions develop.(1)
“The report highlights that each country has different needs and resources; however, we urge all those involved in the management of HCV and public health to help increase awareness of the disease and look at the most effective ways of delivering effective treatment to those most in need,” said Gaston Picchio, Global Hepatitis Disease Area Leader, Janssen. “Janssen is committed to working with the HCV community and will continue to engage with healthcare professionals, government officials and patient advocates around the world to support their efforts to reduce the individual and societal burden of this devastating disease.”
A full copy of the EIU report and supporting materials, including an info-graphic, is available at: http://www.janssen-emea.com/The-silent-pandemic
About HCV
Hepatitis C (HCV) is a blood-borne infectious disease that affects the liver.(3)(4)With an estimated 150 million people infected worldwide,(2) and three to four million people newly infected each year, HCV puts a significant burden on patients and society.(5) Estimations indicate that HCV caused more than 86,000 deaths and 1.2 million disability-adjusted life-years (DALYs) in the WHO European region in 2002 (latest data available).(6) Chronic infection with HCV can lead to liver cancer and other serious and fatal liver diseases.(7) About one-quarter of the liver transplantations performed in 25 European countries in 2004 were attributable to HCV (latest data available).(6)
About Janssen
At Janssen, we are dedicated to addressing and solving some of the most important unmet medical needs of our time in infectious diseases and vaccines, oncology, immunology, neuroscience, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop innovative products, services and healthcare solutions to help people throughout the world. Please visit http://www.janssen.com for more information.
References:
Economist Intelligence Unit. 2012. The Silent Pandemic: Tackling Hepatitis C with Policy Innovation. Available at: http://www.managementthinking.eiu.com/
World Health Organization. Hepatitis C Fact Sheet. Available at: http://www.who.int/mediacentre/factsheets/fs164/en/index.html (last accessed December 2012)
Simin, M et al. 2007. Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C. Alimentary Pharmacology & Therapeutics 25 (10): 1153-62.
Centres for Disease Control and Prevention. Hepatitis C FAQs. Available from: http://www.cdc.gov/hepatitis/C/cFAQ.htm#transmission (last accessed December 2012)
WHO. State of the art of vaccine research and development. Viral Cancers. Available from: http://www.who.int/vaccine_research/documents/Viral_Cancers.pdf (last accessed December 2012)
Muhlberger, N et al. 2009. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 9 (34): 1-14.
Lang K & Weiner DB. 2008. Immunotherapy for HCV infection: next steps. Expert Review of Vaccines 7 (7): 915-923.
Video: http://www.multivu.com/mnr/58671-janssen-silent-pandemic-hepatitis-c
Source: Janssen

Written by asiafreshnews

January 17, 2013 at 2:36 pm

Posted in Uncategorized

Buy and Build a Mobile-Ready Website with Just Your Android

leave a comment »

First ever all-inclusive app for Android makes creating your own website quick, simple and cheap
LONDON /PRNewswire/ — Telnames (http://telnames.com) today released the Android version of its Telnames Mobile Website Builder app. The app enables anyone to buy their own domain name through an in-app purchase and then create a mobile-friendly website in minutes.
“The Telnames Mobile Website Builder app removes all of the complexity of buying and building your own mobile website on a smart phone,” said Khashayar Mahdavi, CEO of Telnames. “Now, with just your Google Play credentials, creating your own website is as simple as downloading a game or movie.”
No other app provides the complete functionality and ease of use to small businesses and professionals who wish to build a website that is suitable for doing business online today that the Telnames app provides. Already, thousands of businesses have gone mobile in minutes with Telnames.
The Telnames Mobile Website Builder is now available as a free download from both the Google Play Store and for iOS device users from the Apple App Store through http://telnamesapps.tel.
About Telnames – http://www.telnames.tel
Source: Telnames

Written by asiafreshnews

January 17, 2013 at 12:22 pm

Posted in Uncategorized

NCP engineering Adds Windows 8 Compatibility to New Version of IPsec VPN Entry and Juniper Clients

leave a comment »

NUREMBERG, Germany /PRNewswire/ —
Version 9.31 Also Optimizes SIM Card Use Through Automatic Access Point Name Management
NCP engineering today announced the availability of a new version of the Entry (http://www.ncp-e.com/en/products/universal-vpn-client-suite.html) and Juniper (http://www.ncp-e.com/en/products/juniper-vpn-client.html) Editions of its IPsec VPN client software. The NCP Secure Clients now fully support Windows 8 (32-/64-bit), offering end users increased device and operating system flexibility when connecting to their corporate networks. NCP’s easy-to-use yet powerful VPN software also enables enterprises to maximize their remote access investments when upgrading from Windows XP/Vista/7 to Microsoft’s latest operating system.
In addition, Version 9.31 contains a new Access Point Name (APN) management feature, which eliminates the need for end users to configure the mobile access point from which they access the Internet. Previously, users who switched out SIM cards from different mobile network operators on their devices were required to tweak these APN settings manually. Now, NCP’s IPsec VPN software automatically prompts the driver to search for and configure the APN via the NetID of the SIM card.
Key Facts
The IPsec VPN client software is equipped with an intuitive graphical user interface that is simple enough for any end user to understand and control. NCP’s solutions also allow for safe and secure connections to corporate networks with a single click-and without needing to worry about firewall settings, device compatibility, connection negotiation or policy requirements.
The NCP Secure Clients bundle support of mobile connect cards, one-time password token and certificate support through a public key infrastructure (PKI), in addition to a dynamic personal firewall, an Internet dialer/connector and seamless roaming across all network connections.
Press Contacts
NCP engineering GmbH
Juergen Hoenig
+49-911-9968151
juergen.hoenig@ncp-e.com
http://www.ncp-e.com
Source: NCP engineering GmbH

Written by asiafreshnews

January 17, 2013 at 11:05 am

Posted in Uncategorized